Companies Dominating the Controlled Release Drug Delivery Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mayne Pharma
- AstraZeneca Plc
- Insulet Corporation
- Becton Dickinson and Co
- Bespak
- West Pharmaceutical Services
- Enable Injections Inc
- Biogen Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of controlled release drug delivery is estimated at USD 64.61 billion.
Controlled Release Drug Delivery Market size was valued at USD 59.83 billion in 2024 and is likely to cross USD 192.37 billion by 2037, expanding at more than 9.4% CAGR during the forecast period i.e., between 2025-2037.
North America industry is expected to account for largest revenue share by 2037, driven by prevailing diseases related to gastrointestinal disorders, advancement in the technological infrastructure of pharmaceutical industry, along with increasing activities of research & development.
The major players in the market are Pfizer Inc., Mayne Pharma, AstraZeneca Plc, Insulet Corporation, Becton Dickinson and Co, Bespak, West Pharmaceutical Services, Enable Injections Inc, Biogen Inc., and others.
